To explore whether the BDNF Val66Met polymorphism could influence the inflammatory response in MS, we analyzed the associations between this SNP and the CSF levels of a large set of pro-inflammatory and anti-inflammatory molecules in a group of relapsing–remitting (RR)-MS patients at the time of diagnosis. Here, BDNF is linked to myeloid sarcoma.